Pulse News Wire translates Japanese corporate disclosures filed with the Tokyo Stock Exchange's TDNet system into clear, structured English for institutional investors, hedge funds, and asset managers. Every article on this page is derived directly from an official TDNet filing — including earnings reports, M&A announcements, share buybacks, dividend declarations, and governance changes. Japanese corporate governance is governed by the Companies Act and the Financial Instruments and Exchange Act; timely translation of these disclosures provides a material information advantage for cross-border investors monitoring Tokyo-listed equities.
This corporate disclosure was processed by Pulse News Wire. It represents a primary source document for Japanese equity sector intelligence, translated directly from an official filing submitted to the Tokyo Stock Exchange TDNet system.
Healios K.K. Reports FY25
Source disclosure: February 16, 2026
HEALIOS K.K. [4593.T]
TOKYO, Feb 19 (Pulse News Wire) – Healios K.K. (4593.T) reported consolidated results for fiscal year 2025 ending December.
Revenue was ¥104 million (-81.4% YoY). operating profit was ¥-3340 million.
Net profit was ¥-2229 million. Total assets stood at ¥6.85 billion with an equity ratio of 39.4%.
For the next fiscal year, the company forecasts revenue of ¥2.27 billion.
AI-translated content. 🟢 Confidence: High See te
TOKYO, Feb 19 (Pulse News Wire) – Healios K.K. (4593.T) reported consolidated results for fiscal year 2025 ending December.
4% YoY).
85 billion with an equity ratio of 39.4%.
For the next fiscal year, the company forecasts 27 billion.
Note: Financial figures from the earnings presentation have been removed pending correction. For accurate figures, refer to the company's earnings summary (kessan tanshin) filed separately on TDNet.